...
首页> 外文期刊>The Egyptian Heart Journal >Successful use of recombinant tissue plasminogen activator (r-TPA) for management of chylothorax associated with central venous thrombosis after neonatal cardiac surgery
【24h】

Successful use of recombinant tissue plasminogen activator (r-TPA) for management of chylothorax associated with central venous thrombosis after neonatal cardiac surgery

机译:成功使用重组组织纤溶酶原激活剂(r-TPA)处理与新生儿心脏手术后中心静脉血栓相关的乳糜胸

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Postoperative chylothorax is a frequently encountered pathology occurring in up to 5% of patients undergoing surgery for repair of congenital heart disease. Neck vein thrombosis can be associated with chylothorax and may contribute to its severity and duration. Furthermore, neck vessel thrombosis resulting in permanent vessel occlusion may hinder future management, diagnostic studies and cardio-surgical interventions. In this report we are describing a neonate who developed chylothorax on the 7th post-operative day following open-heart surgery. The chylothorax was linked to venous thrombosis in the cannulated right internal jugular vein with thrombus extending to the right atrium. After using low dose tissue plasminogen activator (r-TPA) infusion, the thrombi disappeared and the chylothorax resolved with no complications.
机译:术后乳糜胸是一种常见的病理形式,发生率最高为5%的先天性心脏病修复手术患者。颈静脉血栓形成可能与乳糜胸有关,并可能导致其严重程度和持续时间。此外,导致永久性血管阻塞的颈部血管血栓形成可能会阻碍未来的治疗,诊断研究和心脏外科手术干预。在本报告中,我们描述的是在心脏直视手术后第7天出现乳糜胸的新生儿。乳糜胸与右颈内插管的静脉血栓形成有关,血栓延伸至右心房。使用低剂量组织纤溶酶原激活剂(r-TPA)输注后,血栓消失,乳糜胸消失,无并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号